Viewpoints in Glaucoma

The PreserFlo MicroShunt: A Conversation With Dr Ike Ahmed Dr Patel interviews Iqbal "Ike" K. Ahmed, MD, about the PreserFlo MicroShunt, an 8-mm-long tube that is inserted into the eye to help lower eye pressure in glaucoma.
Experts And Viewpoints, May 19, 2022
Cataract Surgery Alone or With the Hydrus Microstent? Dr Patel believes that the HORIZON study 3-year results are important for the understanding of long-term effects on IOP with minimally invasive glaucoma surgery (MIGS) procedures.
Experts And Viewpoints, November 09, 2021
The New Valveless Glaucoma Drainage Device: An Expert's Take Dr Shuchi Patel and Dr Thomas Patrianakos discuss the latter's initial experience using the Ahmed ClearPath.
Experts And Viewpoints, April 28, 2021
The Case for Stand-alone MIGS Gets Stronger New data show meaningful reductions in IOP and medications in pseudophakic patients with open-angle-glaucoma.
Experts And Viewpoints, March 09, 2021
Selective Laser Trabeculoplasty's Value Rises During COVID-19 In this conversation, Drs Shuchi Patel and Teresa Chen talk about how the pandemic is reframing the best first-line treatment for lowering IOP in patients with glaucoma.
Experts And Viewpoints, December 09, 2020
Novel Solutions to Maintain Glaucoma Care During COVID-19 In-person visits are fraught with concern, but virtual replacements won't cut it either. Dr Shuchi Patel looks at some potential alternatives.
Experts And Viewpoints, August 31, 2020
Bimatoprost Implant a Promising Weapon in Fight Against Glaucoma Dr Shuchi Patel says the important question behind the recently approved intracameral biodegradable sustained-release implant isn't whether it works (it does) but rather for how long.
Experts And Viewpoints, June 26, 2020
Is Kahook Dual Blade Goniotomy a Better Option for Glaucoma? Dr Shuchi Patel on how this novel single-use ophthalmic device stacks up against conventional goniotomy and trabectome.
Experts And Viewpoints, May 01, 2020
New Fixed-Dose, Once-Daily Combo Eyedrop Shows Efficacy in Glaucoma There is a sound rationale why combining netarsudil and latanoprost would work so well.
Experts And Viewpoints, September 10, 2019
Two-Stent Injection Lowers IOP in Various Glaucoma Types Dr Shuchi Patel on the latest results with the trabecular microbypass iStent inject.
Experts And Viewpoints, February 25, 2019
Netarsudil Lowers IOP, but When Should It Be Given? Findings from the ROCKET trials shed light on --and also raise questions about --this newly approved medication for glaucoma.
Experts And Viewpoints, January 02, 2019
MP-TSCPC: What We Do and Don't Know Can micropulse transscleral diode laser photocoagulation lower IOP and side effects associated with conventional transscleral diode treatment? Dr Shuchi Patel shares her personal observations.
Experts And Viewpoints, December 16, 2019
(S)pot Check on Alternative Treatments for Glaucoma Does marijuana, gingko biloba, or bilberry effectively manage symptoms of glaucoma?
Experts And Viewpoints, September 17, 2018
'Promising Option' for IOP Reduction A review of the study that led to the recent approval of latanoprostene bunod for open-angle glaucoma and ocular hypertension.
Experts And Viewpoints, June 14, 2018
Trabeculectomy After Failed Glaucoma Drainage Device Surgery Is trabeculectomy a good option for patients with increased IOP after failure of glaucoma drainage device surgery?
Experts And Viewpoints, February 13, 2018
Bimatoprost: Good Option for IOP Reduction in Nonresponders Before using surgical or laser interventions, consider bimatoprost for intraocular pressure (IOP) reduction.
Experts And Viewpoints, November 07, 2017
Efficacy of Gel Microstent for Primary Open-Angle Glaucoma Where does the gel microstent XEN® fall among emerging devices and procedures for IOP reduction in primary open-angle glaucoma?
Experts And Viewpoints, August 23, 2017
Antihypertensives May Cut Glaucoma Risk A Danish Registry analysis looked at the cases of thousands of patients, but potential limitations weaken its conclusion.
Experts And Viewpoints, May 05, 2017
Two-Stent Implantation for IOP Reduction in POAG A recent study shows evidence that two-stent implantation may be a viable first-line therapy for patients with primary open-angle glaucoma.
Experts And Viewpoints, February 17, 2017
OCT for Tracking Glaucoma Progression Researchers hypothesized that the macular ganglion cell layer would prove a more advantageous measure of glaucoma progression, but their results indicated otherwise.
Experts And Viewpoints, November 14, 2016

No Results